Toho Holdings CoFRA:TON 26 Net Margin % is 0.78% as of Mar. 2026, which is 32% below its 10-year median of 1.15. GuruFocus rates FRA:TON with a GF Score™ of 26/100 and a GF Value™ of €25.56 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, Toho Holdings Co ranks worse than 59.83% on this metric.
The historical rank and industry rank for Toho Holdings Co's Net Margin % or its related term are showing as below:
FRA:TON'
s Net Margin % Range Over the Past 10 Years
Min: 0.41 Med: 1.15 Max: 1.4
Current: 1.12
FRA:TON's Net Margin % is ranked worse than 59.83% of 117
companies
in the Medical Distribution industry
Industry Median: 1.47
vs FRA:TON: 1.12
Toho Holdings Co (FRA:TON) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Toho Holdings Co Net Margin % Related Terms
Toho Holdings Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Toho Holdings Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Toho Holdings Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Toho Holdings Co Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Toho Holdings Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Toho Holdings Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Toho Holdings Co (FRA:TON) has a Net Margin % of 0.78% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Toho Holdings Co and its competitors. This is 32% below median its historical median of 1.15. Over the past decade, Toho Holdings Co's Net Margin % has ranged from 0.41 to 1.40. According to the industry distribution chart, Toho Holdings Co ranks #70 out of 117 companies in the Medical Distribution industry, placing it in the top 59.8%.
Is Toho Holdings Co's Net Margin % too high?
Toho Holdings Co's current Net Margin % of 0.78% is 32% below median its 10-year median of 1.15. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 1.40. The Medical Distribution industry median Net Margin % is 1.47. Toho Holdings Co's value of 0.78% is 46.9% below this industry median. Based on the distribution chart, Toho Holdings Co ranks #70 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Toho Holdings Co has a GF Score™ of 26/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Toho Holdings Co's Net Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Toho Holdings Co ranks #70 out of 117 companies for Net Margin %. This places Toho Holdings Co in the lower half of its industry. The industry median Net Margin % is 1.47. Toho Holdings Co's value of 0.78% is 46.9% below this benchmark. Historically, Toho Holdings Co's own Net Margin % has ranged from 0.41 to 1.40 over the past decade. While the company's 10-year median is 1.15 vs. the industry median of 1.47, Toho Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.47, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Toho Holdings Co's current Net Margin % of 0.78% is 46.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Toho Holdings Co and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Toho Holdings Co's current Net Margin % is 0.78%, which is 32% below median its own 10-year median of 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Toho Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Toho Holdings Co (FRA:TON) is currently considered Modestly Undervalued. The stock's GF Value™ is €25.56, compared to a current price of €21.40 — trading 16.3% below its estimated fair value. The current Net Margin % is 0.78%, which is 32% below median its 10-year median of 1.15 and 46.9% below the Medical Distribution industry median of 1.47. Toho Holdings Co's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Toho Holdings Co (FRA:TON), the current Net Margin % is 0.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Toho Holdings Co (FRA:TON) Overvalued in 2026?
Based on GuruFocus' analysis, Toho Holdings Co stock appears to be undervalued.
The current stock price of €21.40 is trading 16.3% below its estimated GF Value™ of €25.56.
GuruFocus considers Toho Holdings Co to be Modestly Undervalued.
Key valuation signals for FRA:TON:
Net Margin %: 0.78% (32% below median its 10-year median of 1.15)
GF Value™: €25.56 vs. price of €21.40 (16.3% below fair value)
Industry Position: 46.9% below the Medical Distribution median (#70 of 117)
No single metric tells the full story. See the FRA:TON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Toho Holdings Co Ltd is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. It also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics, with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. It generates additional revenue through software sales to medical institutions.
26GF Score
Get the complete analysis for FRA:TON
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TON has been successfully added to your 
